Splice Bio closes funding round

We have advised Ysios Capital Partners and Sabadell Asabys in the closing of the funding round obtained by Splice Bio, a Spain-based startup formerly known as ProteoDesign. Splice Bio, based in Barcelona, is engaged in the development of new generation of protein therapeutics using proprietary conjugation technologies.